CHU NANTES;UNIVERSITE DE NANTES;INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
发明人:
HEYMANN, DOMINIQUE,SEGALINY, AUDE,BRION, REGIS
申请号：
CA2971517
公开号：
CA2971517A1
申请日:
2015.12.21
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present disclosure relates to novel anti IL-34 antibodies or antigen-binding fragments thereof specifically binding cytokine IL-34 with high affinity, the method of obtaining of these antibodies and their therapeutic use.
